A novel link of HLA locus to the regulation of immunity and infection: NFKBIL1 regulates alternative splicing of human immune-related genes and influenza virus M gene

Journal of Autoimmunity

Volumn 47, Issue , 2013, Pages 25-33

  An, Jianbo ^a   Nakajima, Toshiaki ^a   Shibata, Hiroki ^a   Arimura, Takuro ^a   Yasunami, Michio ^a   Kimura, Akinori ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Alternative splicing; ASF SF2; CLK1; Immune related gene; NFKBIL1

Indexed keywords

CD45 ANTIGEN; CDC LIKE KINASE 1; INHIBITOR OF KAPPA B LIKE PROTEIN; PROTEIN INHIBITOR; PROTEIN SERINE THREONINE KINASE; PROTEIN TYROSINE KINASE; SERINE ARGININE RICH PROTEIN; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; ARTICLE; CELLULAR DISTRIBUTION; GENE; GENE EXPRESSION; HELA CELL; HLA SYSTEM; HUMAN; IMMUNOPRECIPITATION; INFECTION; INFLUENZA VIRUS M GENE; NFKBIL1 GENE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; TWO HYBRID SYSTEM; VIRUS GENE;

ALTERNATIVE SPLICING; ASF/SF2; CLK1; IMMUNE-RELATED GENE; NFKBIL1;

ALTERNATIVE SPLICING; ANIMALS; ANTIGENS, CD45; AUTOIMMUNE DISEASES; CERCOPITHECUS AETHIOPS; COS CELLS; HEK293 CELLS; HELA CELLS; HISTOCOMPATIBILITY ANTIGENS CLASS II; HLA ANTIGENS; HUMANS; INFLAMMATION; INFLUENZA A VIRUS; NUCLEAR PROTEINS; PROTEIN STRUCTURE, TERTIARY; PROTEIN-SERINE-THREONINE KINASES; PROTEIN-TYROSINE KINASES; RNA INTERFERENCE; RNA, SMALL INTERFERING; RNA-BINDING PROTEINS; VIRAL MATRIX PROTEINS;

EID: 84888202215     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2013.07.010     Document Type: Article

References (34)

1. Allcock R.J., de la Concha E.G., Fernandez-Arquero M., Vigil P., Conejero L., Arroyo R., et al. Susceptibility to multiple sclerosis mediated by HLA-DRB1 is influenced by a second gene telomeric of the TNF cluster. Hum Immunol 1999, 60:1266-1273.
2. Okamoto K., Makino S., Yoshikawa Y., Takaki A., Nagatsuka Y., Ota M., et al. Identification of I kappa BL as the second major histocompatibility complex-linked susceptibility locus for rheumatoid arthritis. Am J Hum Genet 2003, 72:303-312.
3. Yamashita T., Hamaguchi K., Kusuda Y., Kimura A., Sakata T., Yoshimatsu H. IKBL promoter polymorphism is strongly associated with resistance to type 1 diabetes in Japanese. Tissue Antigens 2004, 63:223-230.
4. Shibata H., Yasunami M., Obuchi N., Takahashi M., Kobayashi Y., Numano F., et al. Direct determination of single nucleotide polymorphism haplotype of NFKBIL1 promoter polymorphism by DNA conformation analysis and its application to association study of chronic inflammatory diseases. Hum Immunol 2006, 67:363-373.
5. Kominami S., Tanabe N., Ota M., Naruse T.K., Katsuyama Y., Nakanishi N., et al. HLA-DPB1 and NFKBIL1 may confer the susceptibility to chronic thromboembolic pulmonary hypertension in the absence of deep vein thrombosis. JHum Genet 2009, 54:108-114.
6. Caceres J.F., Kornblihtt A.R. Alternative splicing: multiple control mechanisms and involvement in human disease. Trends Genet 2002, 18:186-193.
7. Chen M., Manley J.L. Mechanisms of alternative splicing regulation: insights from molecular and genomics approaches. Nat Rev Mol Cell Biol 2009, 10:741-754.
8. Lynch K.W. Consequences of regulated pre-mRNA splicing in the immune system. Nat Rev Immunol 2004, 4:931-940.
9. Jacobsen M., Schweer D., Ziegler A., Gaber R., Schock S., Schwinzer R., et al. Apoint mutation in PTPRC is associated with the development of multiple sclerosis. Nat Genet 2000, 26:495-499.
10. Ueda H., Howson J.M., Esposito L., Heward J., Snook H., Chamberlain G., et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 2003, 423:506-511.
11. Semple J.I., Brown S.E., Sanderson C.M., Campbell R.D. Adistinct bipartite motif is required for the localization of inhibitory kappaB-like (IkappaBL) protein to nuclear speckles. Biochem J 2002, 361:489-496.
12. Greetham D., Ellis C.D., Mewar D., Fearon U., an Ultaigh S.N., Veale D.J., et al. Functional characterization of NF-kappaB inhibitor-like protein 1 (NFkappaBIL1), a candidate susceptibility gene for rheumatoid arthritis. Hum Mol Genet 2007, 16:3027-3036.
13. Lamond A.I., Spector D.L. Nuclear speckles: a model for nuclear organelles. Nat Rev Mol Cell Biol 2003, 4:605-612.
14. Colwill K., Pawson T., Andrews B., Prasad J., Manley J.L., Bell J.C., et al. The Clk/Sty protein kinase phosphorylates SR splicing factors and regulates their intranuclear distribution. EMBO J 1996, 15:265-275.
15. Duncan P.I., Stojdl D.F., Marius R.M., Bell J.C. Invivo regulation of alternative pre-mRNA splicing by the Clk1 protein kinase. Mol Cell Biol 1997, 17:5996-6001.
16. Muraki M., Ohkawara B., Hosoya T., Onogi H., Koizumi J., Koizumi T., et al. Manipulation of alternative splicing by a newly developed inhibitor of Clks. JBiol Chem 2004, 279:24246-24254.
17. Rozas J., Rozas R. DnaSP version 3: an integrated program for molecular population genetics and molecular evolution analysis. Bioinformatics 1999, 15:174-175.
18. Tong A., Nguyen J., Lynch K.W. Differential expression of CD45 isoforms is controlled by the combined activity of basal and inducible splicing-regulatory elements in each of the variable exons. JBiol Chem 2005, 280:38297-38304.
19. Wu Z., Jia X., de la Cruz L., Su X.C., Marzolf B., Troisch P., et al. Memory T cell RNA rearrangement programmed by heterogeneous nuclear ribonucleoprotein hnRNPLL. Immunity 2008, 29:863-875.
20. Oberdoerffer S., Moita L.F., Neems D., Freitas R.P., Hacohen N., Rao A. Regulation of CD45 alternative splicing by heterogeneous ribonucleoprotein, hnRNPLL. Science 2008, 321:686-691.
21. Rothrock C.R., House A.E., Lynch K.W. HnRNP L represses exon splicing via a regulated exonic splicing silencer. EMBO J 2005, 24:2792-2802.
22. Lemaire R., Winne A., Sarkissian M., Lafyatis R. SF2 and SRp55 regulation of CD45 exon 4 skipping during T cell activation. Eur J Immunol 1999, 29:823-837.
23. ten Dam G.B., Zilch C.F., Wallace D., Wieringa B., Beverley P.C., Poels L.G., et al. Regulation of alternative splicing of CD45 by antagonistic effects of SR protein splicing factors. JImmunol 2000, 164:5287-5295.
24. Motta-Mena L.B., Heyd F., Lynch K.W. Context-dependent regulatory mechanism of the splicing factor hnRNP L. Mol Cell 2010, 37:223-234.
25. Lynch K.W., Weiss A. Amodel system for activation-induced alternative splicing of CD45 pre-mRNA in T cells implicates protein kinase C and Ras. Mol Cell Biol 2000, 20:70-80.
26. Karlas A., Machuy N., Shin Y., Pleissner K.P., Artarini A., Heuer D., et al. Genome-wide RNAi screen identifies human host factors crucial for influenza virus replication. Nature 2010, 463:818-822.
27. Fodor E., Devenish L., Engelhardt O.G., Palese P., Brownlee G.G., Garcia-Sastre A. Rescue of influenza A virus from recombinant DNA. JVirol 1999, 73:9679-9682.
28. Fodor E., Crow M., Mingay L.J., Deng T., Sharps J., Fechter P., et al. Asingle amino acid mutation in the PA subunit of the influenza virus RNA polymerase inhibits endonucleolytic cleavage of capped RNAs. JVirol 2002, 76:8989-9001.
29. Wang G.S., Cooper T.A. Splicing in disease: disruption of the splicing code and the decoding machinery. Nat Rev Genet 2007, 8:749-761.
30. Krawczak M., Reiss J., Cooper D.N. The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: causes and consequences. Hum Genet 1992, 90:41-54.
31. Zuo P., Manley J.L. Functional domains of the human splicing factor ASF/SF2. EMBO J 1993, 12:4727-4737.
32. Caceres J.F., Krainer A.R. Functional analysis of pre-mRNA splicing factor SF2/ASF structural domains. EMBO J 1993, 12:4715-4726.
33. Mamoune A., Durand V., Le Goff P., Pennec Y.L., Youinou P., Le Corre R. Abnormal distribution of CD45 isoforms expressed by CD4+ and CD8+ T cells in rheumatoid arthritis. Histol Histopathol 2000, 15:587-591.
34. Matthews N., Emery P., Pilling D., Akbar A., Salmon M. Subpopulations of primed T helper cells in rheumatoid arthritis. Arthritis Rheum 1993, 36:603-607.